Hagit Binder
Chief Operating Officer at NEUROSENSE THERAPEUTICS LTD.
Net worth: 27 720 $ as of 29/04/2024
Profile
Hagit Binder is currently the Chief Operating Officer at Neurosense Therapeutics Ltd.
Prior to this, she worked as the VP-Projects & Marketing at Nextar Chempharma Solutions Ltd.
from 2018 to 2022.
Ms. Binder completed her undergraduate, graduate, and MBA degrees at Bar-Ilan University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
31/03/2024 | 22,000 ( 0.13% ) | 27 720 $ | 29/04/2024 |
Hagit Binder active positions
Companies | Position | Start |
---|---|---|
NEUROSENSE THERAPEUTICS LTD. | Chief Operating Officer | - |
Former positions of Hagit Binder
Companies | Position | End |
---|---|---|
Nextar Chempharma Solutions Ltd.
Nextar Chempharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Nextar Chempharma Solutions Ltd. is an Israeli biotechnology company that specializes in brain and central nervous system treatments. The private company is based in Ness Ziona, Israel. In addition to this, Nextar also serves as a contract development and manufacturing organization (CDMO) and has been involved in the development of over 120 innovative products. | Sales & Marketing | 31/12/2021 |
Training of Hagit Binder
Bar-Ilan University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NEUROSENSE THERAPEUTICS LTD. | Health Technology |
Private companies | 1 |
---|---|
Nextar Chempharma Solutions Ltd.
Nextar Chempharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Nextar Chempharma Solutions Ltd. is an Israeli biotechnology company that specializes in brain and central nervous system treatments. The private company is based in Ness Ziona, Israel. In addition to this, Nextar also serves as a contract development and manufacturing organization (CDMO) and has been involved in the development of over 120 innovative products. | Health Technology |
- Stock Market
- Insiders
- Hagit Binder